Safety in terms of incidence and risk factors ocular hyper tension in patients with retinal vein occlusion, diabetic macular edema, postsurgical macular edema and uvietis who were treated with intravitreal dexamethasone implant (ozurdex): An observational, retrospective SAFODEX study

Trial Profile

Safety in terms of incidence and risk factors ocular hyper tension in patients with retinal vein occlusion, diabetic macular edema, postsurgical macular edema and uvietis who were treated with intravitreal dexamethasone implant (ozurdex): An observational, retrospective SAFODEX study

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Jan 2018

At a glance

  • Drugs Dexamethasone (Primary)
  • Indications Diabetic macular oedema; Retinal oedema; Retinal vein occlusion; Uveitis
  • Focus Adverse reactions
  • Acronyms SAFODEX
  • Most Recent Events

    • 24 Jan 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top